Abnormal iron homeostasis and neurodegeneration

dc.contributor.authorMuhoberac, Barry B.
dc.contributor.authorVidal, Ruben
dc.contributor.departmentChemistry and Chemical Biology, School of Science
dc.date.accessioned2025-05-05T08:18:10Z
dc.date.available2025-05-05T08:18:10Z
dc.date.issued2013-07-30
dc.description.abstractAbnormal iron metabolism is observed in many neurodegenerative diseases, however, only two have shown dysregulation of brain iron homeostasis as the primary cause of neurodegeneration. Herein, we review one of these - hereditary ferritinopathy (HF) or neuroferritinopathy, which is an autosomal dominant, adult onset degenerative disease caused by mutations in the ferritin light chain (FTL) gene. HF has a clinical phenotype characterized by a progressive movement disorder, behavioral disturbances, and cognitive impairment. The main pathologic findings are cystic cavitation of the basal ganglia, the presence of ferritin inclusion bodies (IBs), and substantial iron deposition. Mutant FTL subunits have altered sequence and length but assemble into soluble 24-mers that are ultrastructurally indistinguishable from those of the wild type. Crystallography shows substantial localized disruption of the normally tiny 4-fold pores between the ferritin subunits because of unraveling of the C-termini into multiple polypeptide conformations. This structural alteration causes attenuated net iron incorporation leading to cellular iron mishandling, ferritin aggregation, and oxidative damage at physiological concentrations of iron and ascorbate. A transgenic murine model parallels several features of HF, including a progressive neurological phenotype, ferritin IB formation, and misregulation of iron metabolism. These studies provide a working hypothesis for the pathogenesis of HF by implicating (1) a loss of normal ferritin function that triggers iron accumulation and overproduction of ferritin polypeptides, and (2) a gain of toxic function through radical production, ferritin aggregation, and oxidative stress. Importantly, the finding that ferritin aggregation can be reversed by iron chelators and oxidative damage can be inhibited by radical trapping may be used for clinical investigation. This work provides new insights into the role of abnormal iron metabolism in neurodegeneration.
dc.eprint.versionFinal published version
dc.identifier.citationMuhoberac BB, Vidal R. Abnormal iron homeostasis and neurodegeneration. Front Aging Neurosci. 2013;5:32. Published 2013 Jul 30. doi:10.3389/fnagi.2013.00032
dc.identifier.urihttps://hdl.handle.net/1805/47687
dc.language.isoen_US
dc.publisherFrontiers Media
dc.relation.isversionof10.3389/fnagi.2013.00032
dc.relation.journalFrontiers in Aging Neuroscience
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourcePMC
dc.subjectNeurodegeneration
dc.subjectNeuroferritinopathy
dc.subjectFerritin
dc.subjectInclusion bodies
dc.subjectIron
dc.subjectOxidative stress
dc.titleAbnormal iron homeostasis and neurodegeneration
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Muhobera2013Abnormal-CCBY.pdf
Size:
3.14 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: